Please use this identifier to cite or link to this item: http://hdl.handle.net/10316/2805
Title: Enantioselective HPLC-UV method for determination of eslicarbazepine acetate (BIA 2-093) and its metabolites in human plasma
Authors: Alves, Gilberto 
Figueiredo, Isabel 
Castel-Branco, Margarida 
Loureiro, Ana 
Fortuna, Ana 
Falcão, Amílcar 
Caramona, Margarida 
Keywords: eslicarbazepine acetate; BIA 2-093; oxcarbazepine; human plasma; bioanalytical method validation; enantioselective HPLC-UV method
Issue Date: 26-Jun-2007
Publisher: John Wiley & Sons
Citation: Alves,Gilberto et al. - Enantioselective HPLC-UV method for determination of eslicarbazepine acetate (BIA 2-093) and its metabolites in human plasma. Biomed Chromatogr 21 (2007) 1127–1134
Abstract: Eslicarbazepine acetate (BIA 2-093) is a novel central nervous system drug undergoing clinical phase III trials for epilepsy and phase II trials for bipolar disorder. A simple and reliable chiral reversed-phase HPLC-UV method was developed and validated for the simultaneous determination of eslicarbazepine acetate, oxcarbazepine, S-licarbazepine and R-licarbazepine in human plasma. The analytes and internal standard were extracted from plasma by a solid-phase extraction using Waters Oasis® HLB cartridges. Chromatographic separation was achieved by isocratic elution with water–methanol (88:12, v/v), at a flow rate of 0.7 mL/min, on a LichroCART 250-4 ChiraDex (β-cyclodextrin, 5 μm) column at 30°C. All compounds were detected at 225 nm. Calibration curves were linear over the range 0.4–8 μg/mL for eslicarbazepine acetate and oxcarbazepine, and 0.4 – 80 μg/ mL for each licarbazepine enantiomer. The overall intra- and interday precision and accuracy did not exceed 15%. Mean relative recoveries varied from 94.00 to 102.23% and the limit of quantification of the assay was 0.4 μg/mL for all compounds. This method seems to be a useful tool for clinical research and therapeutic drug monitoring of eslicarbazepine acetate and its metabolites S-licarbazepine, R-licarbazepine and oxcarbazepine.
URI: http://hdl.handle.net/10316/2805
DOI: 10.1002/bmc.858
Rights: openAccess
Appears in Collections:FFUC- Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
Biomedical Chrom.pdf214.92 kBAdobe PDFView/Open
Show full item record

WEB OF SCIENCETM
Citations

29
checked on Oct 2, 2021

Page view(s) 50

523
checked on Oct 20, 2021

Download(s) 10

1,706
checked on Oct 20, 2021

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.